Tuberculosis in the European Union and European Economic Area: a survey of national tuberculosis programmes Source: Eur Respir J, 52 (6) 1801449; 10.1183/13993003.01449-2018 Year: 2018
TB and MDR/XDR-TB in European Union and European Economic Area countries: managed or mismanaged? Source: Eur Respir J 2012; 39: 619-625 Year: 2012
The Tuberculosis Network European Trials group (TBnet) ERS Clinical Research Collaboration: addressing drug-resistant tuberculosis through European cooperation Source: Eur Respir J, 53 (1) 1802089; 10.1183/13993003.02089-2018 Year: 2019
Call for urgent actions to ensure access to early diagnosis and care of tuberculosis among refugees: Statement of the European Respiratory Society and the European Region of the International Union Against Tuberculosis and Lung Disease Source: Eur Respir J 2016; 47:1345-1347 Year: 2016
The Tuberculosis Network European Trials Group (TBNET): new directions in the management of tuberculosis Source: Breathe, 13 (3) e65; 10.1183/20734735.005517 Year: 2017
Tuberculosis and HIV co-infection in European Union and European Economic Area countries Source: Eur Respir J 2011; 38: 1382-1392 Year: 2011
TB Portals Program in Ukraine Source: Virtual Congress 2021 – The ongoing threat of drug-resistant tuberculosis Year: 2021
European framework for tuberculosis control and elimination in countries with a low incidence: Recommendations of the World Health Organization (WHO), International Union Against Tuberculosis and Lung Disease (IUATLD) and Royal Netherlands Tuberculosis Source: Eur Respir J 2002; 19: 765-775 Year: 2002
Supervision/monitoring system under the National TB Control Program in Romania Source: Eur Respir J 2005; 26: Suppl. 49, 190s Year: 2005
Severe Paediatric Asthma Collaborative in Europe (SPACE): protocol for a European registry Source: Breathe, 14 (2) 93; 10.1183/20734735.002018 Year: 2018
Drug resistance and HIV rates are high in Eastern European patients with Tuberculosis in a South East London Hospital Source: International Congress 2019 – Extra-pulmonary tuberculosis and comorbidities Year: 2019
Guidance for programmatic management of latent tuberculosis infection in the European Union/European Economic Area Source: Eur Respir J, 53 (1) 1802077; 10.1183/13993003.02077-2018 Year: 2019
European Union Standards for Tuberculosis Care Source: Eur Respir J 2012; 39: 807-819 Year: 2012
A follow up Study of TB patients put on DOTS from South India Source: International Congress 2017 – Clinical challenges in chronic lung diseases Year: 2017
Comparison of tuberculosis surveillance systems in low-incidence industrialised countries Source: Eur Respir J 2008; 32: 1616-1624 Year: 2008
Health Research collaboration in Europe: an innovative initiative Source: Research Seminar 2013 - ERS Presidential Summit on Research gaps, patient needs and innovative solutions: a forward look on lung health research Year: 2013
The ERS European Forum for TB Innovation Source: Annual Congress 2013 –ERS/WHO joint lunchtime session "TB-Forum for innovation" Year: 2013
Estimation of XDR-TB in European part of the Russian Federation Source: International Congress 2016 – Rifampicin resistance, MDRTB, and new drug treatments Year: 2016
Drug-resistant tuberculosis in the European Union and European economic area Source: International Congress 2015 – The emergence of drug-resistant tuberculosis in Europe: no cure possible? Year: 2015